Replimune (REPL)

[jondoeuk]

AACR: Development & characterization of a new oncolytic immunotherapy platform based on herpes simplex virus type 1 https://www.abstractsonline.com/pp8/#!/6812/presentation/2764

A Phase I trial of talimogene laherparepvec combined with neoadjuvant chemotherapy for non-metastatic triple negative breast cancer https://www.abstractsonline.com/pp8/#!/6812/presentation/9841